Your browser doesn't support javascript.
loading
Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial.
Park, Kwonoh; Jeon, Young-Kyung; Kim, Jung Hoon; Choi, Younak; Kim, Jae-Joon; Oh, Sang-Bo; Oh, So Yeon; Hong, Yun Jeong; Huh, Seok Jae; Kim, Ilhwan; Shin, Seong Hoon.
Afiliação
  • Park K; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • Jeon YK; Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea.
  • Kim JH; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • Choi Y; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • Kim JJ; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • Oh SB; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • Oh SY; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • Hong YJ; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • Huh SJ; Department of Neurology, Uijeongbu St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.
  • Kim I; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
  • Shin SH; Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Medicine (Baltimore) ; 102(20): e33638, 2023 May 19.
Article em En | MEDLINE | ID: mdl-37335745
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Fator Estimulador de Colônias de Granulócitos / Neutropenia / Antineoplásicos Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Fator Estimulador de Colônias de Granulócitos / Neutropenia / Antineoplásicos Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2023 Tipo de documento: Article